• Mashup Score: 0
    Medical research funding: Why we must keep our foot on the accelerator - The Cancer Letter - 12 month(s) ago

    It’s been a long time since we’ve seen the kind of strong national commitment that exists today to support medical research. Of course, this enthusiasm is more than justified because of the large number of unprecedented research opportunities that are at the ready to propel us toward defeating cancer and the numerous other diseases that […]

    Source: The Cancer Letter
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Medical research funding: Why we must keep our foot on the accelerator [Jul 21, 2017] Michael Caligiuri @TheCancerLetter https://t.co/oKGYhprsQ3 #NCORP

  • Mashup Score: 0
    Maintaining Predictable Increases in NIH Funding for Cancer Research - The ASCO Post - 12 month(s) ago

    Richard L. Schilsky, MD, FACP, FASCO CONGRESS RECENTLY passed its fiscal year (FY) 2017 spending bill, which contains an additional $2 billion for the National Institutes of Health (NIH). This marks the first time in more than a dozen years that Congress funded back-to-back increases for the NIH, demonstrating the bipartisan consensus that’s been built around the need to support biomedical…

    Source: ascopost.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      MT @rsm2800 RE: @ASCOPost w/ @rschilsky -- Maintaining Predictable Increases in @NIH Funding for Cancer Research [Jul 25, 2017] https://t.co/nYtg448zmH NIH-funded studies dropped from 575 (2008) to 199 (2015) #ClinicalTrials #NCORP

  • Mashup Score: 5
    SWOG Spring 2023 Virtual Meeting Details | SWOG - 1 year(s) ago

    If you are unable to attend the SWOG Spring 2023 group meeting in person you may participate virtually.  Details for the virtual portions of the group meeting will be posted and updated as details are finalized.  Please check back often for updates. Questions? Contact meetings@swog.org. Return to SWOG Spring 2023 Group Meeting page To join…

    Source: www.swog.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of SWOG
      SWOG

      Day 3 of @SWOG spring 2023 group mtg, incl a session on the #microbiome, a plenary on #globaloncology research, an #NCORP site PI mtg, mondo #cancer research cmte sessions, and a Bd of Govs session to select SWOG's next leadership! Join virtually: https://t.co/s2WGkUv1Jh https://t.co/0oaUKAc9lY

  • Mashup Score: 1
    Wolters Kluwer Health - 1 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Source: lww.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      "Without clinical trials, cancer treatment would always remain the same" [Nov 3, 2012] - via @TomBeer in @OncologyTimes https://t.co/QKXVFmyVDG #ClinicalTrials #ctsm #NCORP

  • Mashup Score: 1
    Clinical research by community oncologists - PubMed - 1 year(s) ago

    Practicing and hospital-based community oncologists are increasingly recognized as sources for clinical research activity. Although surveys have documented patients’ and physicians’ willingness to consider participation in clinical research studies, accrual to clinical trials by adults in cancer res …

    Source: PubMed
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      85% of cancer patients are treated in community setting [2003; Feb 23, 2009 online] @GaryCohenMD @CAonline https://t.co/3S36Xxakmp #ClinicalTrials #NCORP

  • Mashup Score: 1
    Clinical trial accrual among new cancer patients at a community-based cancer center - PubMed - 1 year(s) ago

    At the study institution, participation in clinical trials is reported to be low. The unavailability of appropriate clinical trials represents the most significant barrier. Continuing efforts to encourage physicians and to educate patients remain necessary. If the current study findings are found to …

    Source: PubMed
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      #ClinicalTrials accrual among new cancer patients at a community-based cancer center [Jan 15, 2006] @RonaldGoMD et al. Cancer https://t.co/rIFeWGgufU #ctsm #NCORP

  • Mashup Score: 0
    Phase III Clinical Trial Development: A Process of Chutes and Ladders - 1 year(s) ago

    Abstract. Purpose: The Institute of Medicine report on cooperative groups and the National Cancer Institute (NCI) report from the Operational Efficiency Working Group both recommend changes to the processes for opening a clinical trial. This article provides evidence for the need for such changes by completing the first comprehensive review of all the time and steps required to open a phase III…

    Source: American Association for Cancer Research
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Phase III Clinical Trial Development: A Process of Chutes and Ladders [Nov 9, 2010] Dilts, Cheng, Crites, Sandler & Doroshow @CCR_AACR https://t.co/lUxEPa4AqR #ClinicalTrials #ctsm #NCORP 769 steps, 36 approvals

Load More